Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback